Overall, these results suggest that transduction of E2F-1/TatHA fusion proteins in vitro is a moderately effective repressor of hTERT expression in the primary ductal breast cancer cell lines HCC1937 and HCC1599. The gene discussed is E2F1; the disease is breast carcinoma.